414
Views
4
CrossRef citations to date
0
Altmetric
Review

Biologics for Hidradenitis suppurativa: evolution of the treatment paradigm

, , &
Pages 525-545 | Received 07 Sep 2023, Accepted 19 Dec 2023, Published online: 02 Jan 2024

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fabrizio Martora, Claudio Marasca, Sara Cacciapuoti, Federica Fariello, Luca Potestio, Teresa Battista, Massimiliano Scalvenzi & Matteo Megna. (2024) Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study. Clinical, Cosmetic and Investigational Dermatology 17, pages 159-166.
Read now

Articles from other publishers (3)

Yingwei Wang, Tao Yao, Yunlu Lin, Hongping Ge, Bixin Huang, Yu Gao & Jianming Wu. (2024) Association between gut microbiota and pan-dermatological diseases: a bidirectional Mendelian randomization research. Frontiers in Cellular and Infection Microbiology 14.
Crossref
Maria K. Armillei, Ivan B. Lomakin, James Q. Del Rosso, Ayman Grada & Christopher G. Bunick. (2024) Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease. Antibiotics 13:3, pages 270.
Crossref
Dillon Mintoff & Nikolai P. Pace. (2024) Differences in hidradenitis suppurativa patterns of cutaneous involvement between sexes: Insights from a cross-sectional study. Human Immunology 85:2, pages 110764.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.